| Body mass index (BMI) trajectories and risk of ovarian cancer in the PLCO cohort. |
Kaipeng Xie |
Nanjing Medical University |
PLCO |
Jan 17, 2019 |
PLCO-434 |
| Inflammatory potential of diet and risk of breast cancer by menopausal status in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
Kang Wang |
Department of the Endocrine and Breast Surgery, The First Affiliated hospital of Chongqing Medical university |
PLCO |
Jan 15, 2019 |
PLCO-438 |
| PLCO risk assessment formula |
Aharona Shuali |
Nucleix |
PLCO |
Jan 15, 2019 |
PLCO-441 |
| Pre-diagnostic body mass index in relation to hormone receptor positive versus hormone receptor negative breast cancer incidence and mortality |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Dec 28, 2018 |
PLCO-432 |
| A Prospective Study of Inflammation-Based Markers for Lung Cancer Risk and Survival in African Americans |
Brid Ryan |
NCI |
PLCO |
Dec 21, 2018 |
2018-1020 |
| Genetic and environmental determinants of the oral microbiota |
Christian Abnet |
NCI/DCEG |
PLCO |
Dec 21, 2018 |
2018-1016 |
| A Prospective Investigation of Microbial Metabolites and Colorectal Cancer |
Erikka Loftfield |
National Cancer Instiute |
PLCO |
Dec 21, 2018 |
2018-1017 |
| Low dose aspirin use from SQX and risk of ovarian cancer |
Britton Trabert |
University of Utah/Huntsman Cancer Institute |
PLCO |
Dec 18, 2018 |
PLCO-431 |
| Updated data request: Ovarian cancer risk factors by histologic subtypes and development of an ovarian cancer risk prediction model in the Ovarian Cancer Cohort Consortium (OC3) |
Nicolas Wentzensen |
DCEG, NCI |
PLCO |
Dec 11, 2018 |
PLCO-429 |
| Quantifying risk of prostate cancer in men with inflammatory bowel disease. |
Shilajit Kundu |
Northwestern University Feinberg School of Medicine |
PLCO |
Dec 11, 2018 |
PLCO-428 |
| The association of dietary glycemic index and glycemic load on ovarian cancer incidence and survival in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort |
Jennifer Mongiovi |
University at Buffalo |
PLCO |
Dec 11, 2018 |
PLCO-427 |
| Diet, Metabolic Biomarkers and Lung Cancer Risk |
Martin Carl Tammemagi |
Brock University |
PLCO |
Nov 19, 2018 |
PLCO-418 |
| Association of obesity with risk of early-onset cancer: based on PLCO dataset |
Gaoxiang Ma |
China Pharmaceutical University |
PLCO |
Nov 19, 2018 |
PLCO-411 |
| Public Policy Recommendations Towards Colorectal Screenings |
Robert Henderson |
George Mason University |
PLCO |
Nov 13, 2018 |
PLCO-422 |
| Estimating heterogeneous treatment effect of lung cancer in PLCO trial |
Yang Zhao |
Nanjing Medical University |
PLCO |
Nov 13, 2018 |
PLCO-424 |
| A systematic evaluation of environmental and genetic factors associated with incidence and mortality of prostate, lung, colorectal and ovarian cancer. |
Wendy Lam |
The University of Hong Kong |
PLCO |
Nov 13, 2018 |
PLCO-409 |
| Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
PLCO |
Nov 13, 2018 |
PLCO-423 |
| Colonoscopy Adenoma Findings in Different Age Are Associated With Diverse Long-term Colorectal Cancer Incidence |
Xuesi Dong |
Nanjing Medical University |
PLCO |
Nov 7, 2018 |
PLCO-420 |
| NSAID use and ovarian cancer risk of morbidity and survival |
Jieyu He |
Department of Biostatistics, School of Public Health, Nanjing Medical University |
PLCO |
Nov 7, 2018 |
PLCO-421 |
| Association Between Aspirin Use and Risk of Liver Carcinoma: Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and a meta-analysis of 4 cohort studies |
Xuesi Dong |
Nanjing Medical University |
PLCO |
Nov 5, 2018 |
PLCO-419 |
